WORKSPORT PARENT COMPANY FNHI OUTLINES FUTURE VISION IN SECOND PART OF 2018 YEAR IN REVIEW INVESTOR CALL — ON TRACK FOR $5 MILLION IN 2019
Toronto, Ontario, Jan. 09, 2019 – Franchise Holdings International Inc., (OTCQB: FNHI) (or the “Corporation”) Worksport Ltd.’s parent company, in the second part of its 2018 investor conference call, outlined the company’s two tracks for income streams in 2019 — branded and non-competitive private label sales — for its high quality, functional, and aggressively priced […]
Why Clinical Trial Advantages And Regulatory Process In EU May Hold Advantages Over The U.S.
Palm Beach, FL – (January 9, 2018) – Numerous pharma/oncology companies have been conducting their clinical trials overseas for many years due to higher costs and regulations in the US. Among the EU nations though, Poland is regarded as one of the largest clinical trials markets in CEE/CIS and may be the best clinical trial […]
Global EV Demand Drives Scramble for Fresh Supplies of Vital Metals
New York, NY – January 9, 2019: With global electric vehicle (EV) demand growth creating the potential for tight supplies in battery metals such as cobalt, multinational companies and industrialized nations are working to secure these critical metals as prices are projected to rise. The growing market for electric vehicles has led to much […]
Moleculin Announces Patient Recruitment Begins in Annamycin Clinical Trial In Poland
Received European approval to ship Annamycin into Poland to start treating patients HOUSTON – January 9, 2018 – Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System […]
